The Tenth Edition of the Handbook of Clinical Drug Data continues a long
tradition of providing clinically relevant, well-referenced drug information
... [Show More] compiled
by expert clinicians and presented in a compact format. The formats of all
sections should be familiar to users of the ninth edition. As with recent editions,
information in the Handbook is divided into three parts.
Drug Monographs in Part I have been updated to include numerous newly
marketed and promising investigational drugs. Areas with extensive revisions include
the Antivirals reflecting the many new agents for HIV infection, Immunosuppressants,
Anticonvulsants, and the Hematologic Drugs. Three new subsections
have been added to reflect the growing number of agents for rheumatoid
arthritis, glaucoma and osteoporosis: Antiarthritic Drugs in the Analgesic and
Anti-inflammatory Drugs section, Ophthalmic Drugs for Glaucoma in the Central
Nervous System section, and Bisphosphonates in the Renal and Electrolytes
section.
Clinical Drug Information in Part II continues to provide clinically useful
information that helps the reader to decide which drug(s) are most likely to have
caused adverse reactions or which are the best choices for patients in special populations.
All drug-induced diseases sections have been extensively updated, as
have the Cytochrome P450 Interactions, Pregnancy, Breastfeeding, Renal Disease,
Immunization, and Cardiac Arrest sections. Drug-Laboratory Test Interferences
in Part III has also been updated.
In this edition, we welcome several new authors: Dan Baker, Jess Benson,
Toy Biederman, Juliana Chan, Paul Cuddy, Rob DiDomenico, Allison Einhorn,
Ray Hammond, Patty Marshik, Gary Matzke (a returning author), Renée Mercier,
and Anna Taddio (our first “international” author). We would also like to thank
the previous authors whose work in most cases served as the basis for revisions of
the chapters that appear in this edition by new authors: Andrea Anderson (Drugs
and Pregnancy), Lisa Ashton (Respiratory Drugs), Arasb Ateshkadi (Renal and
Electrolytes), Rosemary Berardi (Gastrointestinal Drugs), Larry Borgsdorf (anaphylaxis)
Larry Davis (NSAIDs and Hematologic Drugs), John Flaherty (Aminoglycosides
and β-Lactams), John Gambertoglio (Renal Disease), Millie Gottwald
(Antimigraine Drugs and Neurodegenerative Diseases), Amy Guenette (Inotropic
Drugs and Nitrates), Brian Kearney (Renal Disease), and Carolyn Zaleon (Gastrointestinal
Drugs). We are saddened to report the deaths of Drs. Ateshkadi and
Gambertoglio since our last edition. Both will be remembered for their professional
dedication and the quality of their work. John Gambertoglio had long-time
personal and professional ties to the editors and will be particularly missed.
This edition also marks another major change, being the first edition produced
with our new publisher, McGraw-Hill and new editors, Stephen Zollo and [Show Less]